Art

J-GLOBAL ID：201702247839084541   Reference number：17A1818291

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

黒色腫病期分類:癌米国合同委員会第8版癌病期分類マニュアルにおける根拠に基づく変化【Powered by NICT】

Author (17)： Gershenwald Jeffrey E. (Professor of Surgery and Cancer Biology, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center, The University of Texas MD Anderson Cancer Center, Houston, TX) ,  Scolyer Richard A. (Conjoint Medical Director, Melanoma Institute Australia; Clinical Professor, The University of Sydney, Sydney, New South Wales, Australia) ,  Scolyer Richard A. (Senior Staff Pathologist, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia) ,  Hess Kenneth R. (Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX) ,  Sondak Vernon K. (Chair, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL) ,  Long Georgina V. (Conjoint Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital, Sydney, New South Wales, Australia) ,  Ross Merrick I. (Professor of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX) ,  Lazar Alexander J. (Professor of Pathology, Dermatology, and Translational Molecular Pathology; Director, Melanoma Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX) ,  Faries Mark B. (Co-Director, Melanoma Program; Head, Surgical Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA) ,  Kirkwood John M. (Professor of Medicine, Dermatology, and Translational Science, The University of Pittsburgh School of Medicine, Pittsburgh, PA) ,  McArthur Grant A. (Executive Director, Victorian Comprehensive Cancer Center, Melbourne, Victoria, Australia) ,  Haydu Lauren E. (Manager, Clinical Data Management Systems, The University of Texas MD Anderson Cancer Center, Houston, TX) ,  Eggermont Alexander M. M. (Director General, Gustave Roussy Cancer Institute, Villejuif, France) ,  Flaherty Keith T. (Director, Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, Boston, MA) ,  Balch Charles M. (Professor of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX) ,  Thompson John F. (Professor of Melanoma and Surgical Oncology, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.) ,  for members of the American Joint Committee on Cancer ...
Material： CA. a Cancer Journal for Clinicians  (CA. Cancer J Clin)
Volume： 67  Issue： 6  Page： 472-492  Publication year： 2017 
JST Material Number： A1606A  ISSN： 0007-9235  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： Answer questions and earn CME...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1818291&from=J-GLOBAL&jstjournalNo=A1606A") }}

Thesaurus term： database ,  patient ,  lactate dehydrogenase ,  ulcer ,  clinical trial ,  lymph node ,  *United States of America ,  Mitosis ,  Central Nervous System ,  tumor ,  *manual ,  *Melanoma ,  pathological state
Semi thesaurus term： *病期 ,  *病期分類 , 【Automatic Indexing@JST】

Author keywords (8)： American Joint Committee on Cancer (AJCC) ,  melanoma ,  metastasis ,  pathology ,  prognosis ,  staging ,  survival ,  TNM classification

JST classification (2)： Database systems  (JD03030U) ,  Artificial intelligence  (JE08000Z)

Terms in the title (7)： 黒色腫 ,  病期分類 ,  癌 ,  米国 ,  合同 ,  マニュアル ,  根拠